A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.

Ambühl, Patrice M; Tissot, Alain C; Fulurija, Alma; Maurer, Patrik; Nussberger, Juerg; Sabat, Robert; Nief, Vera; Schellekens, Charlotte; Sladko, Katja; Roubicek, Kirsten; Pfister, Thomas; Rettenbacher, Manfred; Volk, Hans-Dieter; Wagner, Frank; Müller, Philipp; Jennings, Gary T; Bachmann, Martin F

Ambühl, Patrice M; Tissot, Alain C; Fulurija, Alma; Maurer, Patrik; Nussberger, Juerg; Sabat, Robert; Nief, Vera; Schellekens, Charlotte; Sladko, Katja; Roubicek, Kirsten; Pfister, Thomas; Rettenbacher, Manfred; Volk, Hans-Dieter; Wagner, Frank; Müller, Philipp; Jennings, Gary T; Bachmann, Martin F.

Affiliation

Ambühl PM; Renal Division, University Hospital, Zurich, Switzerland.

J Hypertens ; 25(1): 63-72, 2007 Jan.

Article de En | MEDLINE | ID: mdl-17143175

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Virion / Angiotensine-II / Vaccins / Hypertension artérielle / Antihypertenseurs Type d'étude: Clinical_trials / Prognostic_studies Limites: Adult / Animals / Humans / Male / Middle aged Langue: En Journal: J Hypertens Année: 2007 Type de document: Article Pays d'affiliation: Suisse Pays de publication: Pays-Bas

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links